|
End-of-day quote
Egyptian Exchange
2026-10-15
|
5-day change | 1st Jan Change | ||
| 274.25 EGP | -0.99% |
|
-13.07% | +173.65% |
| Market Cap | 13.71B 257M 228M 211M 192M 363M 24.35B 369M 2.54B 996M 12.71B 963M 942M 40.51B | P/E 2025 |
11.7x | P/E 2026 | 32x |
|---|---|---|---|---|---|
| Enterprise Value | 15.25B 285M 254M 235M 214M 404M 27.08B 410M 2.83B 1.11B 14.13B 1.07B 1.05B 45.05B | EV / Sales 2025 |
1.89x | EV / Sales 2026 | 4.56x |
| Free-Float |
20.38% | Yield 2025 |
4.1% | Yield 2026 | - |
| 1 day | -0.99% | ||
| 1 week | -13.07% | ||
| Current month | -13.21% | ||
| 1 month | -14.03% | ||
| 3 months | +41.13% | ||
| 6 months | +172.97% | ||
| Current year | +173.65% |
| 1 week | 241 |  | 318.8 |
| 1 month | 241 | | 368 |
| Current year | 87 | | 516.96 |
| 1 year | 87 | | 516.96 |
| 3 years | 41.3 | | 516.96 |
| 5 years | 24 | | 516.96 |
| 10 years | 8.36 | | 516.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99% | -13.07% | +161.19% | +458.10% | 257M | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,120B | |
| +0.90% | -2.25% | +33.02% | +62.23% | 616B | |
| +0.71% | +3.24% | +25.81% | +93.86% | 504B | |
| -0.13% | +5.98% | +32.91% | +50.39% | 367B | |
| +0.52% | +0.24% | +73.92% | +40.15% | 360B | |
| -0.95% | +4.70% | +19.51% | +43.00% | 288B | |
| -1.98% | +3.73% | -0.86% | +13.43% | 258B | |
| -0.35% | +4.25% | +46.21% | +50.76% | 234B | |
| -0.75% | +3.32% | +32.53% | +97.21% | 194B | |
| Average | -0.26% | +2.27% | +47.77% | +101.30% | 394.12B | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.19% | +71.46% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.29B 24.13M 21.45M 19.88M 18.09M 34.13M 2.29B 34.68M 239M 93.68M 1.19B 90.55M 88.62M 3.81B | 2.13B 39.92M 35.49M 32.89M 29.93M 56.47M 3.79B 57.38M 395M 155M 1.98B 150M 147M 6.3B |
| Net income | 126M 2.35M 2.09M 1.94M 1.76M 3.33M 223M 3.38M 23.3M 9.13M 117M 8.83M 8.64M 371M | 256M 4.8M 4.26M 3.95M 3.6M 6.78M 455M 6.89M 47.5M 18.62M 238M 18M 17.62M 757M |
| Net Debt | 967M 18.1M 16.09M 14.91M 13.57M 25.6M 1.72B 26.01M 179M 70.28M 896M 67.93M 66.48M 2.86B | 1.54B 28.76M 25.56M 23.69M 21.56M 40.68M 2.73B 41.33M 285M 112M 1.42B 108M 106M 4.54B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | EGP 274.25 | -0.99% | 190,335 |
| 26-10-14 | EGP 277.00 | +1.35% | 408,828 |
| 26-10-13 | EGP 273.30 | -7.36% | 436,500 |
| 26-10-12 | EGP 295.00 | -3.00% | 289,460 |
| 26-10-11 | EGP 304.13 | -3.60% | 156,106 |
- Stock Market
- Stocks
- NIPH Stock
Select your edition
All financial news and data tailored to specific country editions
